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Abstract 
 
The objective of this paper is to develop some effective sources of chemotherapeutic agents that 
provide renewable sources of useful antifungal of biodegradable nature which are devoid of side 
effects and thermostable at high temperature with long expiry duration. The essential oil of 
Trachyspermum ammi against human pathogenic fungi in vitro was studied for thermostability, 
storage durability and their effect on human skin. Antifungal activity of the oil was compared 
with some synthetic antifungals. Finally, the essential oil was formulated for clinical trial in the 
form of ointment for clinical investigation. The essential oil of Trachyspermum ammi showed 
strong antifungal activity at 0.1 μl ml-1 concentration against tested pathogens (dermatophytes) 
completely. The oil was found thermostable up to 100oC and did not expire up to 72 months of 
storage. On comparing the antifungal activity of the oil with synthetic antifungals, oil was found 
to be most effective and did not show any adverse effect on mammalian skin up to 1% 
concentration. The oil based ointment, was subjected to topical testing on patients attending out 
patient department (OPD) of M.L.N. Medical College, Allahabad. At the end of the medication, 
70.0% of patients recovered complete cure, 20.0% showed significant improvement from the 
disease. No KOH negative cases of relapse were observed when patients were re-examined after 
two months following the end of treatment. Thus the oil based ointment (products) can be 
recommended for safe, thermostable and long duration effects against dermatophytoses without 
any adverse effect. The commercial viability of the oil can be determined after multicenter 
clinical trials which is in progress. 
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1.0 Introduction 
 
Tinea infections or dermatophytoses is the disease caused by a group of fungi known as 
dermatophytes (Epidermophyton, Microsporum and Trichophyton). Dermatophytoses occur 
more frequently than subcutaneous and systemic mycoses and remain a therapeutic problem in 
tropical and subtropical countries, despite the availability of a number of ointments, lotion, paints 
and powders. Sources of these agents are largely petroproducts that are non-biodegradable and 
causes adverse effects and residual toxicity and other hand these products are thermo labile and 
expire in short duration (maximum 35 month). Naturally occurring antifungals described to date 
are mostly biodegradable [1] and are devoid of side effects [2] compared with commercially 
available antifungals. Recently, some products of higher plant origin have been shown to be 
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effective source of chemotherapeutic agents without undesirable side effects with strong 
fungicidal activity [3-7]. These findings prompted us to explore other plant products (essential 
oil), which could be exploited as effective antifungals. We report here results of our 
investigation, the antifungal activity of the oil of Trachyspermum ammi at various temperature 
and storage durability against, Epidermophyton floccosum (Hartz) Langeron et Milochevitch, 
Microsporum audouinii Gurby,  M. canis Bodin, M. nanum, Fuentes M. gypseum (Bodin) Guiart 
et Grigoraki, T. mentagrophytes (Robin) Blanchard, T. rubrum (Castellani) Sabouraud, T. 
tonsurans Malmstem, T. violaceum (Bodin) as well as clinical investigation in the form of 
ointment for making suitable drug. Tha plant Trachyspermum ammi (L.) Sprangue is a small 
genus of herbs belonging to the family Apiaceae distributed in tropical Africa and from the 
Mediterranean region eastwards though southwestern Asian countries up to India and western 
China. Three species are found in India, of which T. ammi (Ajowan) is the most important and is 
cultivated for its fruits (Ajowan, Omum), which are commonly used as a spice.  
 
 
2.0 Materials And Methods 
 
2.1 Maintenance of human pathogenic fungi 
 
The test pathogens, Epidermophyton floccosum (Hartz) Langeron et Mitochevitch, Microsporum 
audouinii Gruby, M. canis Bodin, M. nanum, Fuentes, M. gypseum (Bodin) Guiart et Grigoraki, 
Trichophyton mentagrophytes (Robin) Blanchard, T. rubrum (Castellani) Sabouraud,                 
T. tonsurans Malmsten, T. violaceum (Bodin) were maintained on Sabouraud dextrose agar 
(SDA) medium. A seven day old culture of test pathogens was used for antifungal study. 
 
2.1.1 Isolation and characterization of essential oil 
 
The essential oil was extracted from the fruits of Trachyspermum ammi by hydrodistillation 
using Clevenger's apparatus [8]. A colorless or brownish yellow colored oily layer was separated 
and dried with anhydrous sodium sulfate. The Physiochemical properties of the oil were 
determined by the technique described by Langenau [9]. Gas liquid chromatography (GLC) 
analysis of the oil was done using a Perkin-Elmer GC model 3920 equipped with TCD and an SS 
column (2 m / 0.125 in × 0.3175 cm) packed with 10% Carbowax 20 m on 80/100 Chromosorb 
WAW. The chromatography was run with column temperature from 600C, with an initial hold of 
8 min; to 1800C at the rate of 2 degree/min with a final hold time of 20 min. A hydrogen flow of 
30 ml/min was maintained through the column. The relative retention and coinjection techniques 
were used to identify the constituents. A Hewlett-Packard integrator (HP 3390A) attached to the 
detector output was used to calculate percent area. 
 
2.1.2 In vitro investigation 
 
The minimum inhibitory concentrations (MIC) of the oil against test pathogens (dermatophytes) 
were determined following the poisoned food technique of Grover and Moore [10] with slight 
modification [6].  
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The nature of antifungal activity (fungistatic/fungicidal) of the oil at MIC was determined by the 
method of Garber and Houston [11]. The inhibited fungal discs (at MIC) were reinoculated up 
side down on plain SDA medium. Inoculated petri plate were incubated at 27 ± 10C, 
observations were recorded on seventh day. Fungal growth on seventh day indicated fungistatic 
action of the oil while absence of fungal growth denoted fungicidal action.  
 
The minimum killing time of the oil was determined by mycelial disc killing technique of Shahi 
et al [6]. Two treatment sets were maintained one with pure oil (100 %) and other with the 
minimum fungicidal concentrations (MCC) of the oil. The treatment sets using MCC of the oil 
was prepared by dissolving the required quantity of the oil samples in 5 ml acetone and then 
added into 100 ml distilled water. Simultaneously, controls were maintained using sterilized 
water (in place of the oil) and acetone adding into the distilled water in appropriate quantities. 
Mycelial discs of 5 mm diameter cut out from the periphery of 7 day old culture of the test 
pathogens were aseptically placed in the culture tubes of different treatment and control sets. 
These mycelial discs were taken out from the tube at different time intervals and washed 
immediately in the washing solution (containing acetone and sterilized distilled water in 1: 2 
ratio) to remove the treatment solution. These washed mycelial discs were aseptically transferred 
up side down to the SDA medium (pH - 5.6) in petri plates. The same procedure was followed 
with the control sets. The inoculated petri plates were incubated at 27 ± 10C and the observations 
recorded on seventh day and calculate the percentage of mycelial growth inhibition according to 
Shahi et al [6]. 
 
The effects of inoculum potentiality at MIC of the oil were determined by the method of Shahi et 
al [7]. Effect of the temperature, on antifungal activity of the oil was evaluated according to 
Shahi et al [7]. Five lots of oil were kept in small vials, each containing 5 ml of oil; these were 
exposed to 40, 60, 80 and 1000C in incubator for an hour. Antifungal activity then tested at MIC 
by the poisoned food technique [10].  
 
Expiry of toxicity of the oil was determined by storing the oil at room temperature (32 ± 40C) 
and antifungal activity were tested at MIC by the regular intervals 60 days up to 72 months 
following the poisoned food technique [10].  
 
To comparative study of the oil with some synthetic antifungals (miconazole, ketaconazole, 
ciclopirox alamine) was carried out by comparing minimum inhibitory concentrations and 
minimum fungicidal concentrations. Various concentrations 0.01 to 10 μl ml-1, of synthetic 
antifungal substances were prepared from their stock solutions by incorporating into adequately 
cooled autoclaved 100 ml SDA medium. In controls, sterilized water (in place of the antifungal 
substances) was used in the medium in appropriate amount. The MIC was assayed following the 
poisoned food technique of Grover and Moore [10]. The nature of toxicity at MIC was 
determined by the method of Garber and Houston [11]. All experiments were repeated twice and 
each contained five replicates; data represent mean values. 
 
 
 
 
2.1.3 In vivo investigation 
Proceedings of the 1st International Conference on Natural Resources Engineering & Technology 2006 
24-25th July 2006; Putrajaya, Malaysia, 45-53 
 
 48
 
To find the maximum tolerable concentrations (MTC) and long term toxicity for irritant activity 
of the oil by their topical application on human skin, following the patch test method as 
described by Shahi et al [6].  
 
People of different sex in the age group of 10 to 30 years were selected randomly and a group of 
30 individuals of each sex was constituted. Circular areas of 5 cm2 on upper hairy and lower 
glabrous surface of palms and 3 cm2 of neck region of each individuals were first washed with 
distilled water followed by 70 % ethyl alcohol and then allowed to dry.  0.2 ml oil of various 
concentrations was applied to each individual separately twice in a day for three week. The 
qualitative observations were recorded after the interval of 24 hr up to three week. 
 
2.1.4 Clinical response of the ointment prepared from the essential oil 
 
The study was designed to see the activity of the essential oil based ointment (1% w/v) on 
patients for the control of tinea infections (dermatophytoses). Medication was administered twice 
a day for 3 week. The patients were not allowed to take any other systemic or topical therapy 
during the course of study. 
 
2.1.4 Patient's selection 
 
Thirty patients of either sex within the age group of 8 to 40 years suffering from tinea corporis, 
tinea cruris or tinea pedis were selected randomly. Patients gave their informed consent to take 
part in this study.  The diagnosis was confirmed mycological by KOH examination. To minimize 
the inconvenience to the patients additional thirty patients were selected as controls. 
 
Patients were examined just before therapy was initiated and at the end of each week for 3 week 
of treatment. Where the cutaneous fungal disease occurred in more than one bodily area, all 
affected areas could be treated, but only one was selected and designated as the reference lesion. 
At each visit, the same reference lesion was scraped for fungal culture to identify the organism 
and for demonstration of hyphae by microscopic examination of the scrapings covered with 10% 
KOH preparations. Signs and symptoms of disease e.i. erythema, oedema, scaling, maceration, 
vesiculation, pustulation, crusting and itching were recorded as absent (-), mild (+), moderate 
(++), or severe (+++) and noted at every visit and scores were added. Less than 25% 
improvement was considered no improvement, 25-50% as mild, 50-75% as moderate, >75% as 
significant and complete cure when there was total clearance of signs and symptoms. Any 
adverse systemic or local reaction was noted at each visit. Satisfactory response with KOH 
negative cases after three weeks were reexamined after two month, to find out the relapse rates. 
 
 
3.0 Results and Discussion 
 
The fruits of T. ammi (Ajowan) on hydrodistilation yield 3.0% essential oil. The physiochemical 
properties of the oil were shown in table 1. The essential oil of T. ammi showed four minor and 
one major components. The percentage purity of the separated fractions was determined using 
analytical gas chromatography and was found to be as follows- fraction A - 0.71%, fraction B - 
1.26 %, fraction C - 9.75 %, fraction D - 12.24 % and fraction E - 72.06 %. These components 
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were identified to be α-pinene, camphene, γ-terpene, p-cymene (minor) and thymol (major) 
respectively (Table 2), using physical constants and by comparison with authentic sample [12]. 
 
Table 1 Physiochemical properties of the oil of T. ammi. 
 
Properties studied       Observations 
Plant height (cm)       158-180  
Oil yield (%)        3.0 
Colour         Brownish yellow 
pH         5.8 
Specific gravity at 250C      0.92231 
Refractive index at 200C      1.5021 
Optical rotation       +3.00 
Saponification value       12.4 
Acid value        3.2 
Ester value        9.2 
Thymol (%)        60-80 
Solubility        90% alcohol  
  
 
Table 2 Chemical constituents above 0.7 % (vol/vol) detected in T. ammi by GLC 
 
Constituents [retention time (min)]      % composition 
 
α-pinenea (2.29)        0.71 
camphenea (3.77)        1.26 
γ-cymenea (9.24)        9.75 
p-cymenea (10.74)        12.24 
thymola (61.71)        72.06 
 
aSeperated and confirmed on an SS column [2 mm by 1/8 in. (0.1375 cm)] packed with 10% OV-
101 on 80/100 chromosorb WHP. The temperature changes and the flow of hydrogen were the 
same as those used for the carbowax 20M column. 
 
3.1 In vitro test 
 
The MIC of the oil of T. ammi were found to be 0.05 μl ml-1 for Microsporum audouinii, 
Trichophyton rubrum, T. interdigetale, T. mentagrophytes, T. tonsurans and 0.1 μl ml-1 for               
E. floccosum, M. canis, M. nanum, T. tonsurans. The minimum fungicidal concentration (MCC) 
were found 0.05 μl ml-1 for M. audouinii, 0.1 μl ml-1 for M. canis, T. rubrum, T. interdegitale,                   
T. mentagrophytes, T. tonsurans 0.2 μl ml-1  for M. nanum, T. violaceum and 0.3 μl ml-1 for          
M. gypseum (Table 3). The oil inhibited heavy doses (30 mycelial discs, each of 5 mm in 
diameter) of fungal inoculum at 0.2 μl ml-1 concentration. The activity of the oil did not expire 
even up to 72 month of storage and persisted up to 1000C temperature. The pure oil (100 %) 
killed the fungi, E. floccosum, M. gypseum, T. rubrum in just 2 sec while at its minimum 
fungicidal concentrations it required 50, 80 and 40 minute respectively (Table 4).  
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Table 3 Minimum inhibitory concentration of the oil of T. ammi against test pathogens 
 
Fungi                Per cent inhibition (MGI %) at various concentrations (μl ml-1) 
       
0.05 0.1 0.2 0.3 0.4 0.5 
 
Epidermophyton floccosum   81.0 100s 100c 100c 100c 100c 
Microsporum audouinii   100c 100c 100c 100c 100c 100c 
M. canis     94.1 100c 100c 100c 100c 100c 
M. gypseum     53.1 67.0 100s 100c 100c 100c 
M. nanum     80.1 100s 100c 100c 100c 100c 
Tricophyton interdigitale   100s 100c 100c 100c 100c 100c 
T. mentagrophytes    100s 100c 100c 100c 100c 100c 
T. rubrum     100s 100c 100c 100c 100c 100c 
T. tonsurans     100s 100c 100c 100c 100c 100c 
T. violaceum     71.8 100s 100c 100c 100c 100c 
 
cFungicidal 
sFungistatic 
MGI, Mycelial growth inhibition 
 
Table 4 Minimum killing time of the oil of T. ammi against test pathogens 
 
Minimum killing time       Percentage of mycelial growth inhibition (MGI) % 
(MKT)     
E. floccosum  M. gypseum  T. rubrum 
     
POa MCCa  PO MCC  PO MCC 
 
120 min   100 100  100 100  100 100 
80   ''    100 100  100 100  100 100 
70   ''    100 100  100 80.9  100 100 
60   ''    100 100  100 76.9  100 100 
50   ''    100 100  100 56.0  100 100 
40   ''    100 93.0  100 41.8  100 100 
30   ''    100 83.0  100 33.1  100 39.0 
60  s    100 --  100 --  100 -- 
30  ''    100 --  100 --  100 -- 
20  ''    100 --  100 --  100 -- 
10  ''    100 --  100 --  100 -- 
2    ''    100 --  100 --  100 -- 
1   ''    63.0 --  78.2 --  83.0 -- 
aPO = Pure oil;  MCC = minimum fungicidal concentration 
 
On comparison the MIC as well as MCC of the oil with those of synthetic antifungal drugs, the 
MIC of the oil was found to be 60, 5, and 3 times more active than that of miconazole, 
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ketoconazole and ciclopirox alamine respectively against E. floccosum, 80, 80 and 6 times 
against T. rubrum, 25, 25 time more active against M. gypseum with that of miconazole and 
ketaconazole respectively. However, these synthetic antifungals were remained fungistatic action 
except ciclopirox alamine (Table 5). 
 
Table 5 Comparative efficacy of the oil of T. ammi with commercial antifungal drugs 
 
Antifungals  Active  Minimum inhibitory and fungicidal concentration (μl ml-1) 
ingredients    
E. floccosum M. gypseum T. rubrum 
   
MIC MCC MIC MCC MIC MCC  
 
Ointment  Essential oil   0.1 0.2 0.2 0.4 0.05 0.1 
Dactrine  Miconazole    6.0 * 5.0 * 4.0 * 
Nizral   Ketoconazole    0.5 * 5.0 * 4.0 * 
Batrafine  Ciclopirox alamine  0.3 1.0 0.1 0.5 0.7 0.5 
 
MIC = minimum inhibitory concentration 
MCC = minimum fungicidal concentration 
* = remained static 
 
3.2 In vivo test 
 
The oil when tested for the irritant activity and long-term toxicity on human skin, the oil 
didn’t show any irritation or adverse effect at 1% concentration up to 3 weeks. 
Formulation was prepared using 1% oil in ointment. After topical application of the 
ointment, improvements were observed right from the first week; 30.0% showed 
moderate improvement and 45.0% mild improvement, while 15.0% showed significant 
improvement. After second week, 25% and 35% patients exhibit significant and moderate 
improvement respectively. However, at the end of medication (i.e. after 3rd week), 70.0% 
of the patients were classed as complete clear and 20.0% as significant improvement 
while 10.0% as moderate improvement (Table 6). Majority of the controls showed no 
improvement and none of them showed more than a mild improvement. 
 
During cost-benefit analysis [6,7] of the oil based ointment compared with synthetic antifungal 
drugs, the ointment was found to be most effective, less expensive (INR. 1.0/gm), long shelf life 
(72 month), thermostable 1000C and absence of any adverse effects. 
 
Gentles [13] was to revolutionize the therapy of ringworm infections. He reported that the oral 
administration of griseufulvin cured experimental dermatophytoses in a guinea pig. Clinical trials 
were carried out in many parts of the world and included the whole gamut of dermatophytic 
disease. These trials conducted by Neves [14], have been reviewed by Blank [15] and are the 
standards for therapy. Recently several new topical drugs have been introduced. Of these, 
tolnaftate (Tinactin) has gained wide popularity but is of limited value in some types of infection. 
More recently a few of the imidazoles- clotrimazole, ketoconazole, miconazole, and econazole- 
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have been used as topical agents in the treatment of certain dermatophyte infections, however, 
these agents are associated with skin sensitization and drug induced eruptions. Treatment failures 
and relapses occur with all presently available drugs. The need for better therapeutic agent is 
apparent. 
 
Table 6 Patients showing clinical response of T. ammi oil based ointment 
 
Parameter   Percentage of patients showing clinical response for three weeks 
           
      1          2         3 
 
T C  T C  T C 
 
No improvement   10 100  00 90  00 80 
Mild improvement   45 00  10 10  00 20 
Moderate improvement  30 00  35 00  10 00 
Significant improvement   15 00  25 00  20 00 
Complete cure     00 00  30 00  70 00  
T test paired deference   
 
SD          53.0       52.0          55.2 
SE of mean         23.7       23.2      24.6 
 
Discovery of essential oils exhibiting narrow/broad spectrum antifungal activity, as suggested in 
the present investigations may prove useful in the development of effective antifungal 
substances.  
 
According to Wellman (16) a fungicide must be retain its antifungal activity at the extremes of 
temperature and must be stable in storage for a long period. In the present study the antifungal 
activity of the oil of T. ammi was found thermostable upto 1000C and activity persisted even 
after 72 month of storage. Hence, the fresh oil can easily be used for developing the ointment 
with out any fear of expiry and did not need for refrigeration in comparison to synthetic 
fungicides. A chemical should be tested under both in vitro and in vivo conditions in order to 
prove its potential as promising antifungal for the control of the disease. Since, detail in vitro 
studies of the essential oil of T. ammi indicate their potentiality as ideal antifungal agents against 
dermatophytes; these were further subjected to in vivo investigation so as to confirm their 
efficacy as therapeutant for the control of dermatophytoses.  
 
According to Polak [17] and Pierard et al [18] the evaluation of antifungal by in vitro and animal 
experiments can not predict clinical efficacy with certainty. Hence the clinical trials conducted 
by Shah et al [6,7] were followed in the present study, to prove the efficacy of the ointment, 
beyond any doubt.  
 
In the present investigation the essential oil of T. ammi interestingly did not show any irritation 
or adverse effect at 1 % concentration on human skin up to three week. Hence, the oil of T. ammi 
due to its strong antifungal activity, inhibiting heavy doses of inoculum with long shelf life, 
thermostable and absence of adverse effect on human skin, this can be used successfully in the 
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form of broad spectrum antifungal treatment against dermatophytoses in human beings. The 
commercial viability of the same can be determined after successful multicenter clinical trial. 
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